Lv21
170 积分 2023-11-03 加入
Metabolic communication in the tumour–immune microenvironment
5小时前
待确认
Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression
5小时前
已完结
Understanding the tumor immune microenvironment (TIME) for effective therapy
6小时前
已完结
Chitosan-based hydrogel wound dressing: From mechanism to applications, a review
10小时前
已完结
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2天前
已完结
Immunotherapeutic approaches for small-cell lung cancer
3天前
已完结
TCR Signaling: Mechanisms of Initiation and Propagation
4天前
已完结
ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion
4天前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
4天前
已完结
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase
4天前
已完结
皖公网安备34019202002308
